The U.S. cannabis industry continues to expand rapidly, creating strong momentum for related investments. In 2025, the market is expected to surpass $44 billion in value. Over the next five years, projections suggest it could reach more than $76 billion. This steady growth is driven by rising consumer demand and ongoing legalization across many states. Currently, nearly half of U.S. adults have tried cannabis at least once. Meanwhile, almost 80% of Americans live near a licensed dispensary. The industry also supports hundreds of thousands of jobs and contributes billions to the economy each year. Because of this, investors are watching cannabis real estate investment trusts (REITs) for potential gains.

At the same time, recent news around federal rescheduling of cannabis has added to investor optimism. If the government moves cannabis to a lower schedule, many operators could see reduced tax burdens. This change would likely attract new capital and improve profitability. States like Pennsylvania are also pushing forward with new legalization bills. These efforts could bring new business to cannabis REITs and boost long-term revenue. However, smart investors must still approach this sector carefully. Using technical analysis helps identify strong price trends and good entry points. Proper risk management, such as stop losses and position sizing, also protects capital. Altogether, staying informed and disciplined is key when trading cannabis REITs in today’s evolving market.

Cannabis REITs to Watch for Long-Term Gains in 2025

As the U.S. cannabis industry expands, real estate investment trusts (REITs) are becoming a critical financing source. These REITs provide essential capital to cannabis companies through sale-leaseback agreements and direct lending. In return, they generate consistent income and strong dividends for shareholders. Moreover, they offer exposure to the cannabis sector without the risks of direct plant-touching operations. In May 2025, three cannabis REITs stand out due to their growing portfolios and resilient financials. These include Innovative Industrial Properties (IIPR), NewLake Capital Partners (NLCP), and Chicago Atlantic Real Estate Finance (REFI).

[Read More] Top Marijuana Stocks In A Volatile Market

Top Cannabis REITs to Watch in May 2025

1. Innovative Industrial Properties, Inc. (NYSE: IIPR)
2. NewLake Capital Partners, Inc. (OTC: NLCP)
3. Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI)

Innovative Industrial Properties, Inc. (IIPR)

Innovative Industrial Properties is the first publicly traded cannabis REIT in the U.S. It focuses entirely on acquiring and leasing facilities to licensed cannabis operators. Founded in 2016, the company has grown steadily across the country. It operates in 19 states, with major footprints in California, Pennsylvania, and Illinois. These regions host large-scale cultivation and processing centers.

The company currently holds over 100 properties. These properties are mostly leased to single tenants under long-term triple-net leases. The tenants include some of the largest U.S. cannabis producers. As a result, IIPR maintains steady rental income even during market downturns. Its focus on real estate allows investors to gain indirect cannabis exposure with reduced volatility.

In Q1 2025, IIPR reported revenue of $71.7 million. This marked a slight increase from the previous quarter. Net income came in at $30.3 million, or $1.03 per share. The company declared a dividend of $1.90 per share. This represents a yield attractive to income-seeking investors. IIPR continues to maintain over $220 million in liquidity. Despite some tenant-related challenges, it has preserved healthy cash flow and balance sheet strength. Its portfolio is diversified, and management remains focused on strategic sale-leasebacks.

[Read More] Top Performing U.S. Marijuana Stocks to Watch in 2025

NewLake Capital Partners, Inc. (NLCP)

NewLake Capital Partners is a cannabis-focused REIT that invests in cultivation and retail properties. Established in 2019, the company has built a diverse portfolio of assets. It currently owns 33 properties across the U.S. These include 15 cultivation facilities and 18 retail dispensaries. The properties are spread across 12 states, including strongholds like Pennsylvania and Ohio.

NewLake’s tenants are major multi-state operators. Companies like Curaleaf and PharmaCann lease several of their facilities. The company operates under a triple-net lease structure. This ensures tenants handle all property expenses while NewLake collects fixed rent. As of May 2025, NewLake’s portfolio is fully leased, and occupancy remains strong.

Financially, NewLake posted $13.2 million in revenue for Q1 2025. This reflected a 4.8% year-over-year increase. Net income was $6.3 million, while adjusted funds from operations totaled $10.7 million. The company declared a $0.43 quarterly dividend, rewarding long-term investors. With over $100 million in available liquidity and a low debt ratio, NewLake is well-positioned for expansion. It has a reputation for responsible capital allocation and consistent rent collections. Management remains focused on adding new properties and deepening relationships with top-tier tenants.

[Read More] Marijuana Stocks To Buy Today And Trade Tomorrow?

Chicago Atlantic Real Estate Finance, Inc. (REFI)

Chicago Atlantic Real Estate Finance operates as a commercial mortgage REIT. Unlike IIPR and NLCP, it does not own physical properties. Instead, REFI provides secured loans to licensed cannabis operators. Its focus is on growth-stage companies with a strong operational history. The REIT specializes in senior secured loans, offering high-interest income and downside protection.

REFI’s portfolio includes 30 active loans totaling over $400 million. These loans are distributed across multiple states and sectors. Borrowers use funds for expansion, equipment, and facility improvements. The company works with experienced operators that meet strict underwriting criteria. This reduces credit risk and supports reliable income generation.

In Q1 2025, REFI reported net interest income of $13 million. Net income reached $10 million, or $0.47 per share. Operating expenses decreased, boosting overall profit margins. The company declared a quarterly dividend of $0.47 per share. This represents a high annualized yield, appealing to income investors. REFI also maintains access to a secured credit facility and holds strong liquidity. With its focus on short-duration loans and consistent underwriting, REFI remains a stable option in a volatile sector. It aims to scale its lending platform while preserving capital discipline.

Cannabis REITs Are Ideal for Long-Term Growth in 2025

Each of these cannabis REITs—Innovative Industrial Properties, NewLake Capital Partners, and Chicago Atlantic Real Estate Finance—brings a unique model to the table. IIPR focuses on real estate ownership and leasebacks. NLCP offers a diversified mix of retail and cultivation assets. REFI prioritizes high-yield lending with strong protections. All three demonstrate consistent revenue, strong dividends, and disciplined management. In a growing industry still underserved by traditional financing, these REITs continue to stand out. Investors seeking cannabis exposure with income stability should keep a close eye on these top-performing REITs in May 2025.

The post 2025’s Best Cannabis REITs for Building Wealth Over Time appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry remains on a strong growth path, with projections estimating a $45 billion market in 2025. More than 20 states now allow adult recreational cannabis use, while others continue expanding medical programs. Recently, lawmakers have debated cannabis reform at the federal level, including rescheduling cannabis to a lower-risk drug classification. This shift could bring major tax relief and open new financial opportunities for cannabis companies. Despite challenges, these changes are fueling optimism across the sector. Penny stocks in this space offer low entry prices and potential for large percentage gains. As the market responds to legislative updates, investor attention has increased on smaller-cap cannabis plays with aggressive growth plans.

Although these stocks carry promise, they also come with significant risks. Many are highly volatile and trade with low daily volume. For this reason, using technical analysis is crucial when watching or trading marijuana penny stocks. Traders should examine key support and resistance levels. It is also smart to use volume indicators and trend confirmation tools. Setting stop-loss orders and managing position sizes can reduce exposure to large losses. Since these stocks can react sharply to news, disciplined entries and exits are essential. Investors must stay alert, follow news catalysts, and apply sound risk strategies. With the right tools and timing, opportunities in marijuana penny stocks can be substantial.

U.S. Cannabis Stocks to Add to Your Radar Now

As the U.S. cannabis industry continues expanding, investors are closely watching select leaders in the sector. In addition, more states are pushing for legalization, which adds to investor optimism. As a result, top-performing marijuana companies are gaining momentum in the market. This article focuses on three U.S. marijuana stocks worth watching in May 2025: Planet 13 Holdings (PLNH), Glass House Brands (GLASF), and Cresco Labs (CRLBF).

Each of these companies has a strong presence in key U.S. markets. They also continue to evolve operationally while navigating regulatory developments. Despite short-term volatility, these stocks have shown resilience and potential for long-term growth. Below is a closer look at each of these top cannabis players, their U.S. dispensary presence, and their latest financial performance.

[Read More] Marijuana Stocks To Buy Today And Trade Tomorrow?

Top U.S. Marijuana Stocks to Watch in May 2025

1. Planet 13 Holdings Inc. (OTC: PLNH)
2. Glass House Brands Inc. (OTC: GLASF)
3. Cresco Labs Inc. (OTC: CRLBF)

Planet 13 Holdings Inc. (PLNH)

Planet 13 Holdings is best known for operating the largest cannabis dispensary in the world. This flagship location is in Las Vegas, Nevada, and spans over 112,000 square feet. The store offers a unique retail experience that blends cannabis shopping with interactive entertainment. Tourists and locals alike visit the store daily, making it a high-traffic location.

The company has also expanded into Florida, which remains one of the fastest-growing medical cannabis markets. Currently, Planet 13 operates 30 dispensaries throughout Florida. It also has one location in Illinois, bringing its total count to 32 dispensaries. Its expansion strategy focuses on large-scale stores in high-demand regions. This allows the company to maintain brand recognition and customer loyalty.

With its growing footprint and strong consumer appeal, Planet 13 remains one of the most prominent names in the cannabis industry. Its multi-state operations continue to drive future growth opportunities.

Latest Financials

In its most recent quarterly report, Planet 13 posted revenue of $28 million. This marked a notable increase from the prior year’s results. The rise in revenue was largely driven by sales in Florida and continued strength in Las Vegas. Gross profits came in at $12 million, with a gross margin just above 42 percent.

Despite solid revenue growth, the company reported a net loss of $2 million. This was due to higher operating expenses tied to expansion efforts. Its adjusted EBITDA showed a loss of $2.5 million. However, management emphasized that short-term losses were strategic. The focus remains on building long-term value through market growth.

Planet 13 has sufficient liquidity to support future investments. Management is optimistic about Florida’s contribution to revenue in future quarters. Overall, the company is positioning itself for improved profitability as it scales.

[Read More] Cultivate Your Portfolio: U.S. Cannabis Stocks for May 2025

Glass House Brands Inc. (GLASF)

Glass House Brands is a vertically integrated cannabis company based in California. The company focuses exclusively on operations within the state. It operates greenhouse cultivation, manufacturing, distribution, and retail stores. This end-to-end control gives the company strong cost advantages.

The company has multiple dispensaries under its Farmacy brand. Most of these stores are located in high-traffic areas in Southern California. In total, Glass House operates eight dispensaries throughout the state. The company is known for its high-quality, sun-grown cannabis. Its cultivation facilities are among the largest in the country.

Glass House continues to expand its greenhouse capacity. This allows it to scale production without significantly increasing costs. The company’s strategy is rooted in operational efficiency and product consistency. As a result, it has become a leader in California’s highly competitive cannabis market. Its premium brand is well recognized by both medical and recreational consumers.

Latest Financials

In its latest earnings report, Glass House generated $44.8 million in revenue, a strong year-over-year increase driven by volume growth. Seasonal demand fluctuations and wholesale pricing pressures impacted the company’s performance, but it managed to maintain growth in core retail locations.

Gross margins remained relatively stable compared to the prior quarter. However, net losses were reported due to temporary increases in labor and facility costs. Management continues to emphasize its commitment to cost control. The company is also investing in automation to enhance productivity.

Cash reserves remain healthy and support ongoing expansion plans. While short-term headwinds persist in the California market, Glass House maintains its long-term bullish outlook. Its large cultivation assets provide a strong advantage. The company believes scale and quality will drive future margins. Therefore, investors continue to monitor Glass House as a top West Coast player.

[Read More]  These Cannabis Stocks Could Pay Off Big In The Future

Cresco Labs Inc. (CRLBF)

Cresco Labs is a multi-state cannabis operator based in Chicago, Illinois. The company is vertically integrated and offers products across nine key U.S. states. Its retail presence includes states like Florida, Illinois, Pennsylvania, and Massachusetts. Cresco Labs markets its dispensaries under the “Sunnyside” brand.

As of May 2025, Cresco operates 71 dispensaries across six states. Its stores are strategically located in both high-density urban centers and suburban areas. The company also owns several well-known consumer cannabis brands. These brands cater to a wide range of user preferences.

Cresco Labs has focused heavily on market depth rather than broad expansion. It prioritizes establishing strong brand loyalty in each region. This approach allows for efficient scaling and better customer service. The company’s mission is to normalize cannabis use through consistent and professional experiences. Cresco remains one of the largest cannabis companies by retail footprint in the U.S.

Latest Financials

Cresco Labs has delayed the release of its Q1 2025 earnings. However, previous performance trends provide some insight. In its last reported quarter, the company generated revenue of over $190 million, supported by strong retail performance in Florida and Illinois.

Gross profit margins hovered around 50 percent, consistent with prior quarters. The company previously reported a net loss, largely due to one-time restructuring costs. However, the adjusted EBITDA remained positive, showing that the business is generating operating cash flow.

Management has reaffirmed its commitment to reducing costs and improving margins. It is also working to optimize its supply chain. The delayed report is expected to include updates on the restructuring’s progress. Despite short-term challenges, Cresco remains financially stable. It continues to focus on market leadership in limited-license states.

U.S. Cannabis Stocks Catching Investor Attention This Week

In conclusion, the U.S. cannabis sector remains a dynamic and evolving space filled with both risk and opportunity. As legalization efforts continue across the country, investor interest in marijuana stocks is expected to grow. Companies like Planet 13, Glass House Brands, and Cresco Labs are positioning themselves for long-term success through strategic expansion and brand development. However, due to market volatility, it is essential to apply technical analysis and manage risk carefully.

Monitoring price action, volume, and key levels can help identify smarter entry points. Setting stop-losses and staying informed on regulatory changes will also support better decision-making. With proper research and a disciplined approach, investors can capitalize on momentum in this exciting sector. As always, focus on strong fundamentals, clear trends, and market-moving news to maximize cannabis-related opportunities. Now is the time to watch these top marijuana stocks as the U.S. industry moves toward broader acceptance.

The post Top Performing U.S. Marijuana Stocks to Watch in 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

In recent weeks, cannabis penny stocks have attracted cautious investor interest. First, the U.S. legal cannabis market reached $33.6 billion in 2023. Moreover, it is projected to grow at a 12.1 percent CAGR through 2030. Meanwhile, employment in the sector surpassed 440,000 full‑time jobs nationwide. At the same time, federal reform remains stalled despite rescheduling momentum. For instance, the DEA’s proposed move to Schedule III could reshape banking access. In addition, states push new bills. Notably, Pennsylvania lawmakers debate privatized dispensaries to unlock $250 million in annual tax revenue. Likewise, the Supreme Court’s recent RICO decision heightens compliance risks across the industry. Therefore, cannabis penny stocks offer both opportunity and volatility this week. Consequently, traders should combine fundamental awareness with market context before entry.

Furthermore, technical analysis can guide precise entry and exit points. For example, watch for clear breakouts above key moving averages. Likewise, identify volume spikes on relative strength index (RSI) signals near oversold levels. At the same time, set stop-loss orders below recent swing lows to limit downside. Moreover, position sizing based on a fixed percentage of portfolio capital prevents outsized losses. In addition, traders should monitor broader market correlations to cannabis ETFs and equities.

Meanwhile, avoid headline risks, such as state-level vetoes or federal delays. Finally, combine chart patterns—like double bottoms or bullish engulfing candles—with strict risk rules. By doing so, investors can pursue gains in penny stocks while containing exposure in this still-evolving industry.

[Read More] These Cannabis Stocks Could Pay Off Big In The Future

Top U.S. Marijuana Stocks to Watch in May 2025

The Cannabist Company Holdings Inc. (OTC: CBSTF)

Cansortium Inc. (OTC: CNTMF) – Doing Business as Fluent

Verano Holdings Corp. (OTC: VRNOF)

The Cannabist Company Holdings Inc. (OTC: CBSTF)

The Cannabist Company, previously known as Columbia Care, is one of the largest vertically integrated cannabis firms in the U.S. Its largest presence is in Florida, New York, and Virginia. As of May 2025, it operates 67 dispensaries across 14 U.S. states. In addition, the company runs 17 cultivation and processing facilities. It offers branded products through in-house lines like Triple Seven and Seed & Strain. Its retail stores are focused on a consistent customer experience. Furthermore, the company has embraced digital marketing and loyalty programs. This helps build stronger customer retention. Recently, it has closed underperforming locations in saturated markets. At the same time, it is focusing on growing markets with long-term upside. These strategic shifts aim to boost margins and reduce overhead. The company focuses on improving operations, scaling sustainably, and navigating changing regulations.

In Q1 2025, the Cannabist Company reported $87 million in revenue. This was slightly lower than the same quarter last year. However, the company improved gross margins by reducing operational costs and optimizing cultivation. Management also reduced SG&A expenses. This improved operational efficiency across its footprint. The net loss narrowed meaningfully compared to the prior year. Additionally, the company successfully restructured a portion of its debt. Lower interest costs are expected in future quarters. Adjusted EBITDA showed improvement, even with modest revenue softness. Cash from operations turned positive for the first time in several quarters. This is a key sign of improving financial health. Liquidity also improved due to better inventory management. Looking forward, management expects stabilization through the second half of 2025. As a result, the company is well-positioned to benefit from future industry growth.

[Read More] Best Canadian Marijuana Stocks for U.S. Market Exposure

 Cansortium Inc. (OTC: CNTMF) – Doing Business as Fluent

Cansortium Inc., now operating as Fluent, is a medical marijuana operator with a strong Florida focus. The company currently operates over 30 dispensaries in Florida alone. Outside Florida, it operates in Texas, Pennsylvania, and New York. Fluent also recently expanded into Ohio, adding several co-located dispensaries. Its brand is built on wellness and customer education. Many locations offer pharmacist-led consultations. This builds trust and improves patient experience. Fluent offers a wide range of products. These include flower, concentrates, tinctures, and pre-rolls. The company continues to grow by adding high-performing retail sites in emerging markets. It also seeks joint ventures and local partnerships to reduce entry barriers. With a vertically integrated model, it controls the supply chain from seed to sale. This gives it pricing flexibility and operational consistency. Fluent remains committed to steady, profitable growth in medically focused markets.

Fluent posted $63.8 million in revenue for Q1 2025. This marked a slight decline year-over-year. Retail sales fell slightly due to price compression, though overall unit volume increased. Wholesale sales declined as bulk deals slowed in some markets. However, states like Virginia and Ohio posted strong retail gains. Gross profit came in at $25.8 million, with margins compressed slightly from prior quarters. Operating expenses totaled $27.6 million, which was a modest improvement. Fluent reported a net loss of $17 million in Q1. Interest expenses and depreciation continued to weigh on results. However, adjusted EBITDA was $9.8 million, down from $13.3 million in the previous year. Despite short-term softness, the company’s financials are stabilizing. Investments in Ohio and Virginia are expected to deliver growth in future quarters. Fluent is also improving cash flow and reducing non-essential costs. These steps should help strengthen its financial foundation.

[Read More] 3 Marijuana Stocks For Long-Term Investing 2025

Verano Holdings Corp. (OTC: VRNOF)

Verano Holdings is a major multi-state cannabis operator based in Chicago. It operates in 16 U.S. states and serves both medical and adult-use markets. As of May 2025, Verano runs more than 100 dispensaries. Its largest retail presence is in Florida, Illinois, and Nevada. Verano is known for its premium retail brands like Verano and MÜV. These stores are highly curated and focus on customer experience. The company also owns cultivation and processing facilities in key states. It uses vertical integration to manage costs and ensure consistent product quality. Verano expands through both organic growth and acquisitions. Recent moves have focused on acquiring licenses in underserved regions. It also partners with local operators to reduce risk. Leadership has emphasized careful scaling and integration. As a result, the brand reputation remains strong across regions. The company’s structure supports long-term scalability and margin growth.

In Q1 2025, Verano reported $210 million in revenue. This marked a strong increase compared to the prior year. The company recorded a net loss of $12 million for the quarter. However, adjusted EBITDA improved as gross margins expanded. Verano also generated $2 million in operating cash flow. Although capital expenditures remained high, the company managed costs effectively. Its balance sheet remains healthy, with reasonable levels of debt and cash on hand. Management continues to reinvest in new store openings and cultivation upgrades. These investments are expected to fuel future revenue growth. The company aims to reach profitability by late 2026. Analysts have highlighted Verano’s disciplined approach as a key advantage. By focusing on core markets and sustainable operations, it has built a resilient business model. Financial performance is expected to improve further as markets mature and efficiencies scale.

Leading U.S. Marijuana Stocks for May 2025

May 2025 presents a unique moment for cannabis investors. The U.S. industry is expanding amid evolving legalization trends. Companies like The Cannabist Company, Fluent, and Verano offer diverse exposure. Each firm operates in multiple states and controls a significant market share. Despite recent margin pressures, they are improving operational efficiency and cash flow. These names are well-positioned for long-term success in the cannabis sector. For investors, they represent top U.S. marijuana stocks to watch in 2025.

The post Cultivate Your Portfolio: U.S. Cannabis Stocks for May 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues to surge, reaching an estimated $45 billion in 2025. Analysts expect it to grow to over $75 billion by 2030. With federal reform discussions advancing and legalization expanding, Canadian cannabis companies are positioning for growth. Many are making strategic moves to increase their U.S. exposure through acquisitions and partnerships.

This momentum has sparked investor interest in Canadian companies with operational ties to the U.S. These firms aim to capture future demand while waiting for federal legalization. This week, three stocks stand out: Tilray Brands Inc., Canopy Growth Corporation, and Village Farms International Inc. Each has taken bold steps to improve financial health and boost cross-border expansion. Let’s explore how these companies are performing and why they’re worth watching now.

[Read More] 3 Marijuana Stocks For Long-Term Investing 2025

Top Canadian Cannabis Stocks to Watch in May 2025

1. Tilray Brands Inc. (NASDAQ: TLRY)
2. Canopy Growth Corporation (NASDAQ: CGC)
3. Village Farms International Inc. (NASDAQ: VFF)

Tilray Brands Inc. (TLRY)

Tilray Brands Inc. is a diversified cannabis company with exposure to both wellness and beverage sectors. The company operates in Canada, Europe, and across the U.S. through THC-infused beverages and hemp-based products. In the U.S., Tilray distributes its THC drinks in over 10 states via various retail partnerships. Although it doesn’t own dispensaries, its beverages are stocked in liquor stores and convenience chains nationwide.

Tilray is also active in global markets. It has operations in Germany, Portugal, and Australia. These regions support both medical and recreational growth. Within North America, Tilray’s strategy focuses on consumer-packaged goods and market penetration through scalable partnerships. The company’s U.S. exposure continues to grow despite regulatory barriers.

In April 2025, Tilray reported its Q3 fiscal 2025 earnings. The company posted revenue of $185.8 million, slightly lower than last year. Gross profit rose 5% to $52 million. Gross margin improved to 28%, driven by cost controls and high-margin products.

Tilray’s cannabis segment delivered its strongest margin in two years. This result indicates progress in operational efficiency. However, the company posted a net loss of $793.5 million. This was mostly due to non-cash impairment charges that impacted reported earnings. Tilray also reduced its overall debt by $76 million. This move shows a commitment to long-term financial sustainability. Investors continue to monitor Tilray’s beverage expansion and cost-reduction initiatives for future performance.

[Read More] Top 3 Marijuana Stocks For Better Investing 2025

Canopy Growth Corporation (CGC)

Canopy Growth Corporation is one of the best-known cannabis producers in Canada. The company has multiple brands, including Tweed, Tokyo Smoke, and Martha Stewart CBD. Canopy has shifted its U.S. strategy through Canopy USA. This structure gives it exposure to American operators while complying with federal law.

Canopy USA controls stakes in several U.S. companies, including Wana, Jetty, and Acreage. These firms give Canopy access to edibles, vapes, and flower products. While Canopy cannot yet directly operate dispensaries in the U.S., this setup keeps it prepared for future legalization. The company’s brand portfolio remains one of its strongest assets.

In February 2025, Canopy reported its Q3 fiscal 2025 results. The company generated $74.8 million in revenue, a 5% drop from the prior year. However, revenue increased by 8% when excluding divested businesses. The company also reported a $24 million operating loss, but this marked a 61% improvement year-over-year.

Canopy’s medical cannabis business in Canada showed continued strength. International markets also contributed to stable revenue, especially in Europe. To improve its balance sheet, Canopy prepaid a $100 million loan. This will reduce interest costs and improve cash flow. Management continues to focus on operational efficiency and margin recovery. Investors are watching closely to see how U.S. political changes could impact Canopy’s expansion plans.

[Read More] Here Is How The Cannabis Industry Impacts The Public Sector

Village Farms International Inc. (VFF)

Village Farms International began as a greenhouse vegetable grower. It later pivoted into cannabis production through its Pure Sunfarms subsidiary. The company now operates as a vertically integrated cannabis and produce business. While Village Farms doesn’t yet own dispensaries in the U.S., it maintains agricultural operations in Texas and has plans for wellness-based expansion.

Pure Sunfarms is one of Canada’s most profitable cannabis producers. It is known for its cost efficiency and strong margins. Village Farms leverages its farming expertise to scale its cannabis operations. The company’s ability to manage multiple product lines gives it a unique position in the market.

On May 12, 2025, Village Farms reported its Q1 2025 earnings. Consolidated revenue came in at $77.1 million. This was slightly down from the $78.1 million posted a year earlier. However, its Canadian cannabis segment delivered a net income of $3 million. This was a 258% increase compared to the prior year.

Adjusted EBITDA for that segment grew by 64% to $6.7 million. These results highlight the strength of the company’s cannabis operations. Meanwhile, the produce segment continues to face weather-related challenges. To address this, Village Farms announced plans to privatize part of its produce business. This move allows the company to focus resources on higher-growth cannabis operations. Investors are optimistic that this shift will unlock more value in the quarters ahead.

Top Canadian Pot Stocks to Buy Before U.S. Federal Reform

Canadian cannabis companies are no longer just domestic players. Each of these three stocks—Tilray, Canopy, and Village Farms—offers a unique path into the growing U.S. market. They are actively restructuring operations, improving balance sheets, and expanding strategic footprints.

Tilray leads with beverages and CPG products. Canopy is leveraging brand strength and U.S. subsidiaries. Village Farms stands out with operational efficiency and profitability. All three companies have shown improvements in key financial metrics this year.

Still, cannabis remains a volatile sector. News, politics, and regulations can move these stocks quickly. As always, traders should use technical analysis and risk management strategies. Identify trend direction, volume changes, and support levels before making entries. Use stop losses to protect capital. Stay informed, stay flexible, and keep an eye on these leaders as the cannabis market heats up in 2025.

The post Best Canadian Marijuana Stocks for U.S. Market Exposure appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Curaleaf International, part of Curaleaf Holdings, Inc. (TSX: CURA) in collaboration with Jupiter Research LLC, a subsidiary of TILT Holdings Inc. (“TILT”) (Cboe CA: TILT) (OTCPK: TLLTF), has secured regulatory approval for the first handheld liquid inhalation device designed for precise medical cannabis administration. This EU medical device certification (Regulation (EU) 2017/745) paves the way for improved patient options and a new era of innovation in medical cannabis delivery.

The liquid inhalation device is now certified as a Class IIa medical device, meeting rigorous European regulatory standards. The device includes a magnetic snap-in cartridge and a rechargeable power supply, engineered to provide a consistent and controlled cannabinoid delivery. A comprehensive technical file and full EU Declaration of Conformity were assessed and approved by a recognised EU Notified Body, validating the device’s quality, safety, and clinical robustness.

EU certification supports deployment in multiple global markets and once commercialised, will enable healthcare professionals to recommend the device offered by Curaleaf International in countries including European countries, the UK, Canada, and regions across Australasia.

Boris Jordan, Chairman and CEO of Curaleaf, commented on this achievement:
“Achieving EU medical certification is more than a regulatory milestone—it’s a signal that medical cannabis innovation is moving into the mainstream of global healthcare. We’re proud to offer a device that meets the highest standards of safety and quality, and we look forward to supporting patients and healthcare providers across Europe and beyond with a new, accurate and discrete option for treatment.”

Echoing this sentiment, TILT’s Chief Executive Officer Tim Conder, added:
“Partnering with Curaleaf International on this project has been a natural extension of our long-standing partnership in the US. By delivering industry-leading, user-friendly solutions, our collaboration exemplifies how technology can revolutionise healthcare. Achieving EU medical certification on IP developed by our subsidiary Jupiter Research, validates the robustness of our engineering and R&D functions and sets a new benchmark for the industry.”

This development reinforces Curaleaf International’s role at the forefront of advancing access to legal, high-quality cannabis treatments across Europe and other international markets.

About Curaleaf International
Curaleaf International is shaping the future of cannabis through its commitment to research and product excellence. Powered by a strong presence at all stages of the supply chain, its unique distribution network throughout Europe, Canada and Australasia brings together pioneering research with cutting-edge cultivation, extraction, and production. Amidst a rapid growth trajectory, the emphasis on quality and expertise aims to ensure the delivery of safe and legal cannabis.

Curaleaf International’s network includes a clinic, pharmacy, and laboratory in the UK; cultivation and EU-GMP processing facilities in Portugal; an EU-GMP processing, quality assurance and research site in Spain; Four20 Pharma wholesaler and distributor in Germany; a Polish wholesaler and clinic; and the EU-GMP producer Northern Green Canada.

Curaleaf International is part of Curaleaf Holdings, Inc., a leading international producer and distributor of consumer cannabis products.

About TILT and Jupiter Research
TILT Holdings manages a diverse portfolio of companies in the cannabis industry, encompassing technology, hardware, cultivation, and production. Its core business, Jupiter Research LLC, is a wholly owned subsidiary and a global distribution leader in the vaporization segment. Jupiter is dedicated to hardware design, research, development, and distribution to support cannabis brands and retailers across the United States, Canada, South America, and the European Union. Additionally, TILT is a multi-state operator, with cultivation and production facilities in three states under the Commonwealth Alternative Care and Standard Farms brands. For more information, visit www.tiltholdings.com.

Media Contact:

Curaleaf International:
Beth Sweet-Escott
Head of Communications, Curaleaf International
media@curaleafint.com

TILT:
Lynn Ricci
VP of Investor Relations & Corporate Communications, TILT Holdings Inc.
lricci@tiltholdings.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/curaleaf-international-in-partnership-with-jupiter-research-secures-eu-medical-device-certification-for-europes-first-handheld-liquid-inhalation-device-302451697.html

SOURCE Curaleaf International

The post Curaleaf Holdings, Inc (CURLF) Secures EU Medical Device Certification for Europe’s First Handheld Liquid Inhalation Device appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry is poised for continued growth in 2025. Market estimates suggest it could exceed $45 billion in total value this year. This growth is fueled by rising consumer demand and expanding access in newly legalized states. Recently, multiple states have advanced adult-use legislation, creating fresh momentum. As legalization efforts gain traction, more companies are entering the market. This trend provides new opportunities for investors focused on undervalued cannabis stocks. Many penny stocks in the sector are gaining attention due to strong volume and low price points. Therefore, marijuana penny stocks could offer explosive upside for short-term and long-term traders alike.

However, these stocks often come with heightened volatility. For this reason, technical analysis becomes essential. Traders should focus on support and resistance levels, trend confirmation, and trading volume. Additionally, proper risk management is critical. Always use stop-loss levels and size positions based on account risk. While potential gains can be substantial, downside moves can also be sharp. Consequently, disciplined strategies are key when trading marijuana penny stocks.

Marijuana Stocks With Breakout Charts

The U.S. cannabis sector continues to show long-term promise despite recent volatility. Several stocks are now catching the attention of traders and investors. This May, three companies stand out due to their size, recent expansion, and updated financial performance. These include The Cannabist Company, Cansortium Inc., and Verano Holdings. Each has made operational changes, opened new locations, or shifted strategy to gain market share.

As the industry evolves, picking stocks with strong fundamentals becomes more important. Regulatory news, consumer demand, and retail access will drive momentum. These three operators are expanding across high-growth states like Florida, Pennsylvania, and Illinois. With smart technical analysis and proper risk management, they may offer favorable setups. Now let’s look at each company in detail, starting with The Cannabist Company.

[Read More] Here Is How The Cannabis Industry Impacts The Public Sector

Top 3 Marijuana Stocks to Watch in May 2025

1. The Cannabist Company Holdings Inc. (OTC: CBSTF)
2. Cansortium Inc. (OTC: CNTMF)
3. Verano Holdings Corp. (OTC: VRNOF)

The Cannabist Company Holdings Inc. (CBSTF)

The Cannabist Company is one of the largest vertically integrated cannabis operators in the United States. Formerly known as Columbia Care, it runs dispensaries in 14 states. Its largest presence is in Florida, New York, and Virginia. The company operates 67 active dispensaries nationwide. In addition, it controls 17 cultivation and processing facilities.

The Cannabist retail brand offers a consistent experience across locations. It features premium cannabis products, including flower, vape cartridges, and capsules. The company owns and promotes in-house product lines such as Triple Seven and Seed & Strain. It aims to build customer loyalty through rewards and digital platforms. Recently, management has focused on streamlining operations and reducing costs. This includes closing underperforming dispensaries in mature markets.

Latest Financials

In its latest quarterly report, the company reported a slight decline in total revenue. Sales dropped due to pricing pressure and store closures. However, management has taken active steps to stabilize margins. This includes trimming SG&A expenses and exiting lower-margin states. Net loss improved compared to the prior year, showing better efficiency.

The company also restructured a significant portion of its outstanding debt. This reduces interest expenses and frees up cash for expansion. Gross profit margins improved as production costs fell in newer facilities. Overall, the balance sheet shows signs of recovery. If trends continue, revenue could stabilize by the second half of 2025. Investors are watching closely for guidance in the next earnings release.

[Read More] Investing in Green: Top U.S. Marijuana Stocks for May 2025

Cansortium Inc. (CNTMF)

Cansortium Inc., now doing business as Fluent, is a Florida-based cannabis company. It focuses on high-growth medical markets with strong consumer demand. The company’s largest presence is in Florida, where it operates over 30 dispensaries. It also has licenses in Texas, Pennsylvania, and New York. The Fluent brand emphasizes clean cultivation and pharmacist-led guidance.

Each Fluent location offers a wide selection of products, including tinctures, oils, vapes, and edibles. The company prides itself on professional service and clinical support. It continues to expand its cultivation capacity, targeting efficiency and quality. Plans include increasing canopy space and upgrading extraction capabilities. Florida remains the core growth engine, but expansion into Pennsylvania offers upside potential.

Latest Financials

Cansortium posted double-digit revenue growth year over year. The gains were driven mainly by Florida sales. Margins expanded as operating costs were held steady during the quarter. EBITDA also improved, thanks to higher average ticket prices and better product mix. The company remains cash flow positive and continues to pay down debt.

Capex has been controlled, with capital directed to proven markets. Management expects more growth from upcoming dispensary openings. Their financial forecast indicates rising revenue over the next two quarters. Key risks include regulatory delays and slower-than-expected market development in new regions. However, strong execution in Florida gives the company a firm foundation. Investors view this as one of the more stable micro-cap operators in the U.S.

[Read More] Top Marijuana Stocks With Upside Potential In The Market

Verano Holdings Corp. (VRNOF)

Verano Holdings is a major cannabis operator with a strong footprint across the U.S. Headquartered in Chicago, it is active in 13 states. Its largest market is Florida, where it now runs 81 dispensaries. The company also has a growing presence in New Jersey, Illinois, and Arizona. Its two key retail brands are Zen Leaf and MÜV.

Verano offers a full line of cannabis products, including flower, pre-rolls, vapes, and infused gummies. The company owns several in-house brands designed to appeal to different customer segments. These include Savvy, BITS, Avexia, and Encore. It has over 1 million square feet of cultivation space. The business is vertically integrated, giving it control over pricing, distribution, and supply chain. This helps maintain high product consistency across states.

Latest Financials

Verano reported annual revenue approaching $850 million last year. It remains one of the top earners in the cannabis sector. The company has faced recent net losses due to high operating costs and depreciation. However, adjusted EBITDA remains positive. Cost-cutting programs are underway to improve profitability. The Florida market has been especially strong, contributing a large share of total revenue.

New dispensaries continue to open on a monthly basis. The company forecasts further growth in adult-use states like New Jersey and Connecticut. It is also investing in automation to lower production costs. Debt levels are being managed carefully, and liquidity appears stable. Analysts are looking for signs of margin recovery in upcoming quarters. Long-term, Verano is viewed as a potential consolidator in the U.S. market.

[Read More] High Potential: Canadian Cannabis Stocks Making Waves in May 2025

Top Pot Penny Stocks to Watch Closely in May 2025

The cannabis industry remains volatile but filled with opportunity. Companies with strong fundamentals and multistate operations are best positioned for the future. The Cannabist Company, Cansortium Inc., and Verano Holdings all meet those criteria. Each is expanding in high-demand states and actively improving financials. With careful chart analysis and smart entry points, these stocks could offer attractive setups in May 2025

The post Best Cannabis Penny Stocks for Your May 2025 Trading Watchlist appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues to grow rapidly. Experts predict it could contribute over $120 billion to the national economy in 2025. This surge is fueled by increasing demand, expanding legalization, and broader acceptance. Currently, over 20 states have legalized recreational marijuana, and more are exploring similar moves. Recent headlines point to bipartisan efforts in several states pushing for full legalization. As regulations shift, investor interest in cannabis stocks continues to rise. Among them, marijuana penny stocks are gaining momentum due to their high-risk, high-reward nature. These low-priced shares often react sharply to news, market sentiment, and legislative developments. Therefore, they offer unique opportunities for traders looking for volatility and upside. However, not every stock is worth the risk. Identifying quality companies is essential. Timing also matters. That’s where strategy and analysis come in. Let’s explore how to approach these stocks wisely.

Marijuana penny stocks can move fast, so preparation is key. Traders should rely on technical analysis to guide decisions. Tools like moving averages, RSI, and volume spikes help confirm trends and potential breakouts. Support and resistance levels also offer crucial insight. However, strategy means little without discipline. Using stop-loss orders can prevent large drawdowns. Managing position sizes also helps limit risk exposure. Many penny stocks trade on low volume, so entry and exit timing become even more important. Additionally, it’s wise to watch overall market sentiment. Cannabis stocks tend to follow broad sector momentum. When volume surges and catalysts align, breakouts can be explosive. But sharp pullbacks are also common. Therefore, staying nimble is essential. Focused watchlists and clear trade plans can offer an edge. With the right setup and discipline, marijuana penny stocks can offer compelling opportunities this week.

[Read More] Top Marijuana Stocks With Upside Potential In The Market

U.S. Marijuana Stocks Showing Strong Performance

The U.S. cannabis sector remains one of the fastest-growing industries despite recent volatility. In May 2025, several leading operators are drawing attention from investors. Regulatory momentum continues to build, and many companies are positioning for long-term growth. With improving margins and tighter cost controls, top multi-state operators are starting to stand out.

Three U.S. marijuana stocks with solid fundamentals and strong retail footprints include AYR Wellness, Cresco Labs, and Curaleaf Holdings. Each company is advancing its market share while reducing expenses and boosting cash flow. As traders seek quality setups, these stocks offer compelling potential based on technical and fundamental factors. However, risk management and timing remain essential. Let’s take a closer look at each of these leading cannabis operators.

Top-Performing U.S. Marijuana Stocks to Watch in May 2025

1. AYR Wellness Inc. (OTC: AYRWF)
2. Cresco Labs Inc. (OTC: CRLBF)
3. Curaleaf Holdings Inc. (OTC: CURLF)

AYR Wellness Inc. (AYRWF)

AYR Wellness is a vertically integrated cannabis company with a focus on medical and adult-use markets. The company operates across eight U.S. states. Its largest presence is in Florida, where it has over 60 dispensaries. In total, AYR operates 97 retail locations, with a growing footprint in Ohio and Pennsylvania. The company also has operations in Massachusetts, New Jersey, and Connecticut. Recently, it gained approval to enter Virginia with a full vertical license. This strategic expansion supports its long-term growth objectives.

AYR focuses on disciplined spending and operational efficiency. It has also invested in cultivation, particularly in Florida. A large indoor facility is currently under development. This will improve consistency and supply chain flexibility. Despite competition, AYR continues to open new locations in key markets. It aims to build strong regional leadership in each state it operates. This focus on footprint quality over size has become a core part of its strategy.

In its latest quarterly report, AYR posted revenue of $114 million, which marked consistent sequential growth. Adjusted gross margins came in at 49%, reflecting improved operational execution. AYR generated $9.6 million in cash flow from operations during the quarter, helping it finish the year with $35.5 million in cash. Capital expenditures were limited to $17.7 million for the full year, which was well below initial guidance.

The company also completed several debt restructurings. These efforts pushed major maturities to 2026 and reduced near-term financial pressure. AYR’s EBITDA for the quarter came in at $19.1 million. This demonstrated early success in stabilizing margins and improving cash flow. Despite macro headwinds, management expects steady performance in the year ahead. Their focus will remain on profitable growth and cost control.

[Read More] High Potential: Canadian Cannabis Stocks Making Waves in May 2025

Cresco Labs Inc. (CRLBF)

Cresco Labs is a leading multi-state cannabis operator with a broad retail and wholesale presence. The company is well known for its Sunnyside dispensary brand. It operates across several large cannabis markets, including Illinois, Pennsylvania, and Massachusetts. Cresco holds the number one market share in multiple states. The company currently runs over 60 dispensaries nationwide. It also maintains one of the largest branded product portfolios in the cannabis space.

Cresco focuses heavily on compliance, quality, and consumer trust. Its retail strategy is patient-focused, offering personalized service and premium experiences. The company also maintains cultivation and processing facilities in each state it operates. Recently, it expanded cultivation in Pennsylvania and added operations in new medical markets. These efforts support both wholesale distribution and in-house retail supply.

In 2024, Cresco reported $724 million in revenue. While this marked a 6% decline year-over-year, profitability improved. The company generated $364 million in gross profit and $200 million in adjusted EBITDA. This represented a 15% increase from the previous year. Operating cash flow came in at a record $132 million. This was a 126% increase from 2023. Cresco attributed the gain to better expense management and margin expansion.

Free cash flow was positive as well, further improving the company’s balance sheet. Inventory controls and disciplined capital allocation drove better financial outcomes. Management noted significant improvements in pricing discipline and cost per gram. These metrics continue to support future profitability. With strong brand loyalty and operational scale, Cresco remains well-positioned for continued expansion in 2025. Analysts expect it to maintain top-tier margins across core markets.

[Read More] Best Cannabis Penny Stocks to Add to Your May 2025 Watchlist

Curaleaf Holdings Inc. (CURLF)

Curaleaf Holdings is the largest cannabis operator in the U.S. by revenue and dispensary count. It currently operates 151 retail locations across 17 states. Its largest concentration is in Florida, where it runs 66 dispensaries. The company also has a growing international footprint, with recent product launches in Europe. In the U.S., Curaleaf has focused on high-volume markets and scale efficiencies. Its rebranding initiatives in Nevada and infrastructure upgrades highlight its evolving retail strategy.

Curaleaf is known for its wide selection of products and broad distribution. It serves both medical and recreational consumers. Its stores are designed for high traffic and convenience, driving repeat business. The company also emphasizes digital ordering and loyalty programs. These tools support customer retention and higher basket sizes. In addition to its dispensaries, Curaleaf operates several processing and cultivation sites across the country.

In 2024, Curaleaf generated $1.34 billion in revenue. This marked one of the highest totals in the U.S. cannabis sector. Gross profit for the year reached $639.2 million, with adjusted EBITDA of $300.8 million. The company produced $163.3 million in operating cash flow and $70.1 million in free cash flow. Despite a net loss of $216.2 million, management expressed confidence in its financial path forward.

Key growth drivers include vertical integration, brand expansion, and margin improvement. The company also refinanced certain credit facilities to enhance liquidity. In 2025, Curaleaf will focus on organic growth through its “Return to Our ROOTS” plan. This includes store-level optimization, margin expansion, and strategic debt reduction. Overall, Curaleaf’s scale and diversification offer strong long-term upside as legalization momentum builds.

These three cannabis stocks continue to separate themselves from weaker players in the space. With operational discipline, expanding retail footprints, and improving financials, AYRWF, CRLBF, and CURLF deserve a place on every marijuana investor’s watchlist in May 2025.

The post Investing in Green: Top U.S. Marijuana Stocks for May 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues to gain momentum in 2025. Experts estimate the market will surpass $45 billion this year. Many states are pushing new legislation to legalize adult-use cannabis. Recreational marijuana is now legal in almost half of the United States. This trend boosts investor confidence across the North American cannabis sector. Canadian companies with exposure to the U.S. market stand to benefit. Recent discussions at the federal level signal possible regulatory reform. These changes may include reclassifying cannabis to a lower risk category. If approved, this could open doors for wider medical research and commercial growth. Therefore, Canadian cannabis stocks are worth watching this week. They offer exposure to both Canadian and potential U.S. demand. Investors are watching for the next catalyst that could move these stocks sharply.

At the same time, it is critical to use technical analysis and proper risk management. Cannabis stocks can be highly volatile. Traders often look for breakout patterns and support zones on price charts. These patterns help identify high-probability entry points. Risk management involves setting stop-loss levels and avoiding oversized positions. It’s important to stay patient and avoid emotional trades. Because cannabis stocks react strongly to policy headlines, investors should track news closely. But no strategy is complete without discipline. Staying consistent with chart analysis and risk control helps limit damage from sudden reversals. As a result, combining market awareness with technical tools can lead to better decisions. This week, several Canadian stocks are forming key setups. Traders should stay focused and use risk control to capitalize on these potential moves.

[Read More] These 3 Marijuana Stocks Could Be The Winners You Need

Top Canadian Cannabis Stocks to Watch in May 2025

1. Tilray Brands Inc. (NASDAQ: TLRY)
2. Canopy Growth Corporation (NASDAQ: CGC)
3. Village Farms International Inc. (NASDAQ: VFF)

Tilray Brands Inc. (TLRY)

Tilray Brands Inc. is a Canadian-based cannabis company with global operations. It focuses on cannabis, wellness products, and beverages. In the U.S., Tilray has expanded its presence through partnerships and acquisitions in the craft beer and wellness industries. Though it does not directly operate cannabis dispensaries in the U.S., its brand awareness is growing. Its beverage brands are distributed in multiple states. Tilray’s strategy includes waiting for U.S. federal legalization before deeper cannabis integration. Meanwhile, the company maintains a strong distribution network across North America. It continues to be one of the most recognized names in the cannabis industry. Its diversification outside of cannabis helps reduce reliance on one sector. Therefore, Tilray remains a unique play among Canadian cannabis stocks. As legalization efforts expand, investors keep Tilray on their radar. Its U.S. strategy hinges on long-term positioning rather than short-term dispensary count.

Latest Financials

Tilray’s latest financial report showed steady revenue growth despite challenges. Revenue increased slightly year-over-year, driven by stronger cannabis sales and beverage distribution. However, net losses remained substantial due to impairments and restructuring charges. Gross margins improved thanks to operational efficiencies and product pricing strategies. The company also lowered debt through repayments, helping improve its overall balance sheet. Cash reserves stayed healthy, giving it flexibility in future expansion. Operating costs remained high, but management has taken steps to reduce them. Tilray adjusted its full-year revenue outlook to reflect current market trends. While the company is not yet profitable, it continues to focus on long-term sustainability. Investors are watching closely for further improvements in earnings and margins. Continued growth in its beverage segment adds diversity. The company’s U.S. exposure offers long-term upside once federal reform occurs. Risk remains, but Tilray’s brand power and footprint provide a foundation for future performance.

[Read More] The Best Marijuana To Make Potential Profits In 2025

Canopy Growth Corporation (CGC)

Canopy Growth Corporation is another leading cannabis company based in Canada. It operates internationally with strong medical and recreational cannabis divisions. Canopy does not own or operate U.S. dispensaries but has set up structures to enter once legal barriers fall. The company holds strategic stakes in several American cannabis firms, preparing for a post-legalization landscape. Canopy has built brand equity through innovative cannabis formats. These include dried flower, vapes, edibles, and medical-grade cannabis products. In Canada, Canopy remains a top-five cannabis supplier by market share. The company continues to focus on research and development to support product quality. Additionally, Canopy maintains a presence in medical cannabis markets across Europe and Australia. Though not directly present in U.S. retail, its groundwork may pay off. With U.S. legalization gaining momentum, Canopy could enter more aggressively. Its patient approach is designed to minimize legal risks while maximizing potential entry.

Latest Financials

Canopy’s recent financials reflect both progress and challenges. Revenue declined slightly but remained stable compared to peers. Sales growth in medical cannabis and international markets helped offset declines in other segments. The company saw increased sales from higher-margin products like vaporizers and medical offerings. However, Canopy continues to report operating losses as it invests in restructuring. The company narrowed its focus, divesting from underperforming businesses and assets. Cost-cutting measures began to show results through smaller quarterly losses. Cash reserves declined but remained adequate to support operations through 2025. The company also reduced its debt obligations through early repayments. While losses persist, the path toward leaner operations is becoming clearer. Gross margin improvements are encouraging signs of better efficiency. Analysts are cautiously optimistic, awaiting signs of revenue reacceleration. Canopy’s long-term plan depends heavily on U.S. legalization. Until then, the focus remains on global medical markets and streamlining operations.

[Read More] Top Cannabis REITs to Watch for High Dividends and Long-Term Growth in 2025

Village Farms International Inc. (VFF)

Village Farms International Inc. started as a greenhouse vegetable producer before pivoting to cannabis. The company now operates a large cannabis segment under the Pure Sunfarms brand. It is known for cost-efficient cultivation and a vertically integrated business model. Pure Sunfarms is one of Canada’s largest cannabis producers by volume. While Village Farms has no retail dispensaries in the U.S., it distributes CBD and hemp products across several states. Its U.S. exposure comes mainly through its Texas-based vegetable business and its hemp operations. The company has positioned itself to expand in the U.S. cannabis market once legalization advances. Meanwhile, its Canadian operations continue to grow steadily. Village Farms relies on its agricultural expertise to maintain low production costs. It also benefits from tight quality control since it handles cultivation, packaging, and distribution internally. This structure allows the company to adjust faster to changing market demands.

Latest Financials

Village Farms’ most recent earnings showed strength in its Canadian cannabis division. Revenue grew at a double-digit pace due to higher sales volume. However, operating expenses and inventory write-downs weighed on profitability. Gross margins remained competitive, thanks to low production costs. The company faced short-term headwinds but expects improvements in the second half of 2025. Village Farms extended its compliance period with the Nasdaq due to a low share price. Management expressed confidence in regaining compliance without a reverse split. The company also announced upcoming financial updates and strategic reviews. Its balance sheet remains stable, with moderate debt and consistent cash flow. Operating efficiency has improved year-over-year despite macroeconomic pressure. Village Farms’ long-term strategy includes expanding internationally and preparing for U.S. cannabis entry. The stock remains volatile, but value investors appreciate its low cost base. Its conservative capital management provides some downside protection for long-term holders.

Blooming Opportunities: Top Canadian Cannabis Investments This May

In May 2025, Tilray, Canopy Growth, and Village Farms represent three very different cannabis investment stories. Tilray offers diversification and brand recognition. Canopy Growth provides international exposure and regulatory preparedness. Village Farms brings cost leadership and operational focus. Each company faces headwinds, yet each is well-positioned to benefit from future industry growth. Investors should monitor key financial metrics and policy changes. Technical analysis and risk management remain crucial when trading cannabis stocks. As the U.S. edges closer to federal reform, Canadian players could gain significant ground.

The post High Potential: Canadian Cannabis Stocks Making Waves in May 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues to expand, driven by rising demand and broader state-level legalization. By the end of 2025, analysts expect the market to exceed $45 billion in value. Currently, adult-use cannabis is legal in nearly half of the U.S. states. This trend fuels investor interest, especially in marijuana penny stocks. These low-priced equities offer high-risk, high-reward opportunities. Because of their affordability, they attract retail traders seeking large percentage gains. As legalization advances, more small-cap cannabis firms are positioned for explosive growth. Therefore, keeping these stocks on a weekly watchlist is a smart move for active traders.

However, it’s essential to apply disciplined strategies. Marijuana penny stocks are highly volatile and can change direction quickly. Technical analysis helps traders identify support and resistance levels. It also highlights potential breakout patterns and price reversals. Just as important, risk management protects capital. Traders should use stop-loss orders and avoid overexposure. With proper strategy and timing, these stocks can present compelling short-term opportunities.

Here are three top marijuana stocks to watch in May 2025: Planet 13 Holdings (PLNH), FLUENT Corp. (formerly Cansortium, CNTMF), and Ayr Wellness (AYRWF). Each company has a significant presence in the U.S. cannabis market and has shown notable developments in recent financials.

[Read More] The Best Marijuana To Make Potential Profits In 2025

Weekly Watchlist: Promising Marijuana Penny Stocks with Breakout Potential

1. Planet 13 Holdings (OTC: PLNH)
2. FLUENT Corp. (formerly Cansortium, OTC: CNTMF)
3. Ayr Wellness (OTC: AYRWF)

Planet 13 Holdings (PLNH)

Planet 13 Holdings is a vertically integrated cannabis company headquartered in Las Vegas, Nevada. It operates the world’s largest dispensary, located just off the Las Vegas Strip. In addition to its flagship location, Planet 13 has expanded its footprint across several states. As of April 2025, the company operates 37 dispensaries nationwide, including 33 in Florida. This expansion into Florida has been a significant growth driver for the company.

Latest Financials

In Q4 2024, Planet 13 reported revenue of $30.3 million, marking a 31.8% increase year-over-year. This growth was primarily driven by the company’s expansion in Florida. However, the company faced challenges with a net loss of $26.4 million, which included an $18.9 million non-cash impairment loss. The gross profit for the quarter was $13.1 million, representing a margin of 43.2%, down from 47.8% in the previous year. The decline in gross margin was attributed to industry-wide price compression and targeted discounting in Florida. Despite these challenges, Planet 13’s expansion strategy and strong presence in key markets position it as a notable player in the cannabis industry.

[Read More] Top Cannabis REITs to Watch for High Dividends and Long-Term Growth in 2025

FLUENT Corp. (formerly Cansortium, CNTMF)

FLUENT Corp., previously known as Cansortium Inc., is a multi-state cannabis operator based in Tampa, Florida. The company operates under the FLUENT brand and has a significant presence in Florida, Texas, Pennsylvania, and New York. As of early 2025, FLUENT has expanded its operations through the acquisition of RIV Capital, adding New York retail, wholesale, and cultivation operations to its portfolio. This strategic move has enhanced FLUENT’s footprint in the U.S. cannabis market.

Latest Financials

In 2024, FLUENT reported annual revenue of $103.6 million, reflecting a 6.4% year-over-year increase. The company’s Q4 2024 revenue was $24.9 million, a slight decrease compared to the previous year. Florida operations contributed significantly, with revenue at $20.3 million. Adjusted gross profit for the quarter was $10.0 million, representing 40.1% of revenue. Adjusted EBITDA stood at $3.0 million, driven by higher sales in Florida. FLUENT’s strategic acquisitions and consistent financial performance make it a noteworthy company in the cannabis sector.

[Read More] April 2025 Ancillary Cannabis Stock Watchlist: Three Companies Powering the Industry

Ayr Wellness (AYRWF)

Ayr Wellness is a vertically integrated, multi-state cannabis operator headquartered in Miami, Florida. The company operates over 90 licensed dispensaries across eight states, including Florida, Pennsylvania, and New Jersey. Ayr has been focusing on expanding its retail footprint and enhancing its product offerings to cater to a diverse customer base.

Latest Financials

For the full year 2024, Ayr Wellness reported generating $9.6 million in cash flow from operations. The company ended the year with a cash balance of $35.5 million, down from $50.6 million at the end of Q3 2024. In addition, Ayr secured $30 million in financing for a new Florida cultivation facility and successfully deferred $400 million in debt maturity to 2026. Despite revenue headwinds, Ayr’s strategic financial decisions and expansion efforts position it as a significant player in the cannabis industry.

Top Undervalued Cannabis Penny Stocks for Technical Traders

These companies—Planet 13 Holdings, FLUENT Corp., and Ayr Wellness—have demonstrated significant developments in their operations and financials, making them noteworthy stocks to watch in the cannabis sector for May 2025.

The post Best Cannabis Penny Stocks to Add to Your May 2025 Watchlist appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Marijuana stocks have slowly started to see more momentum enter the sector. This could be due to concerns settling down after not seeing any drastic changes. When Trump became president there was a spike in fear about what happened while in office. Parts of his cabinet wanted to end legal markets as a whole. All this added more weight to the downtrend and impacted investors’ confidence.

However, over the last few weeks, there has been a bit more momentum to slowly enter the market. Now this would not be what a bounce looks like but more so of sign of confidence. The thing is the cannabis industry as a whole even with all its progress is still evolving. This can lead to market changes for marijuana stocks yet often what a company does doesn’t always translate to its stock rising.

Right now it’s about strategizing for the future and setting up your portfolio for potential long-term gains. Cannabis stocks are in a volatile environment so trading can change without warning. That is why having a plan on how you will trade or find marijuana stocks to add to your portfolio is keen. Below are several marijuana stocks to watch that could be future gainers as things continue to push forward in the market.

Top Marijuana Stocks For You 2025

1. Green Thumb Industries Inc. (OTC:GTBIF)
2. Curaleaf Holdings, Inc. (OTC:CURLF)
3. Cresco Labs Inc. (OTC:CRLBF)

Green Thumb Industries Inc.

Green Thumb Industries Inc. manufactures, distributes, markets, and sells cannabis products for medical and adult use in the United States. It operates through two segments, Retail and Consumer Packaged Goods.

In more recent news the company announced it has opened a new storefront. This new RISE dispensary is located in Ocala FL and makes for Green Thumbs 104th retail location in the nation.

Words From The Company

“We are thrilled to open our first RISE Dispensary in Ocala, where our cultivation/production facility has already brought close to 100 jobs to the community. We are honored to create more job opportunities through the opening of RISE Dispensary Ocala while also bringing well-being to more Florida patients,” said Green Thumb President Anthony Georgiadis.”

Curaleaf Holdings, Inc.

Curaleaf Holdings, Inc. produces and distributes cannabis products in the United States and internationally. On April 17th the company announced the expansion of its retail footprint with the opening of a new store.

The company opened a new medical cannabis dispensary in Winter Park, Florida. This new Winter Park location makes for Curaleaf Holdings, Inc. 5th dispensary in the greater Orlando area.

Words From The CEO

“Our continued expansion in the Sunshine State reflects our strong commitment to the medical community and the ongoing growth of the Florida market,” said Boris Jordan, Chairman and CEO of Curaleaf.”

[Read More] Top Cannabis REITs to Watch for High Dividends and Long-Term Growth in 2025

Cresco Labs Inc.

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States. On April 29th the company announced it will soon report its Q1 2025 earnings.

The company has set May 9th before the market opens as when the official release will be. So Cresco Labs Inc. will host a conference call and webcast to discuss its financial results. As well as provide investors with key business highlights.

The post The Best Marijuana To Make Potential Profits In 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..